Cricketer Pat Cummins backs longevity startup Everlab’s $65 million Series A - Startup Daily

2026-06-16 · Source: Series A" OR "Series B" OR "Series C" AI startup via Google News · Field: Health & Wellbeing — Medical Devices & Health Technology, Public Health & Epidemiology · Depth: Fundamental Awareness, quick

Summary

Preventative healthcare startup Everlab has secured \$65 million in Series A funding, led by Airtree Ventures with support from Plural, b2venture, and existing investor Left Lane Capital. Australian test captain Pat Cummins also participated as an angel investor. This capital infusion will fuel the three-year-old Melbourne-based company's expansion into the UK and enhance its clinical and technology infrastructure. Everlab, which previously raised a \$3 million pre-Seed round in December 2023 and a \$15 million Seed round in July 2025, offers AI-enhanced preventative healthcare advice. Its digital app integrates advanced biomarker diagnostics, doctors, specialists, prescriptions, and continuous AI care, processing over 200,000 health reports monthly. The platform has analyzed more than 20,000 clients in Australia and New Zealand, detecting previously undetected health issues in over 25% of them.

Key takeaway

For investors evaluating health tech startups, Everlab's successful \$65 million Series A, rapid expansion, and proven ability to detect health issues in over 25% of clients highlight strong market validation. You should consider models that integrate AI with extensive clinical networks and biomarker diagnostics. This approach addresses fragmented healthcare, offering a clear path to global scalability and significant patient impact.

Key insights

AI-enhanced preventative healthcare leverages biomarker diagnostics to detect early health issues and coordinate personalized care.

Principles

• Fragmented health systems hinder patient care.
• Early detection prevents disease progression.
• Integrated digital platforms streamline healthcare.

Method

Everlab's method involves advanced biomarker diagnostics, AI analysis, and a digital app to organize specialists, prescriptions, and continuous care for personalized health plans.

In practice

• Offer comprehensive health checks (\$299) and specialized tests.
• Integrate with 1,850+ provider locations and 30+ wearable devices.
• Target executive programs for corporate clients.

Topics

• Preventative Healthcare
• AI Diagnostics
• Biomarker Testing
• Health Tech Funding
• Digital Health Platforms
• Global Expansion

Best for: Entrepreneur, Investor, Consultant

Related on AIssential

• Exclusive: General Catalyst backs YC alum Lucis in $20m Series A — AI-powered preventative health platforms are attracting significant Series A investment, particularly in Europe.
• Doctors May Soon Be Able to Diagnose Illnesses Before You Ever Feel Sick — AI can predict disease onset by monitoring dynamic molecular network instability before symptoms appear.
• I Sold My Startup A Year After Founding It. Here’s Why That Was The Fastest Way To Build Real-World Healthcare AI — Clinical AI success requires deep integration within existing healthcare systems to achieve real-world reliability and impact.
• Triomics Raises $22M to Scale Oncology AI for Early Cancer Detection and Treatment — Oncology AI firm Triomics raised \$22M to scale its technology for early cancer detection and treatment.
• 01Health secures $15M to scale specialist healthcare platform — 01Health's platform decentralizes specialist healthcare by empowering local clinics with integrated technology and AI.
• Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468] — Proactive health strategies, leveraging existing and AI-accelerated medicines, can drive a trillion-dollar public health revolution.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Series A" OR "Series B" OR "Series C" AI startup via Google News.